GlobalData (GB:DATA) has released an update. GlobalData Plc has executed a share buyback program, purchasing 250,000 of its own shares at a ...

A GlobalData analyst has warned that Trump's second term could see major changes in US healthcare, and RFK could rock the ...

This report from GlobalData will help you better understand the potential impact of Trump 2.0 on the Automotive industry.

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

With Donald Trump securing his return to the White House for a second term, we explore what his second term could mean for ...

Slowing electric-vehicle adoption is likely to accelerate even further as President-elect Donald Trump delivers on his ...

Previous United Nations COP (Conference of the Parties) events indicate that they are increasingly less impactful, but that enterprise communications service providers should continue to lead the way ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist. These tests raise concerns ...

A previous version of this article incorrectly said that U.S. restaurant spending is expected to reach $1.22 billion in 2024, ...